| Active substance |
Clomid |
| Also known as |
Clomifene Citrate, Clomid, Serophene |
| Blood pressure |
Generally does not affect blood pressure significantly |
| Chemical name |
2-[4-(2-chloro-1,2-diphenylethenyl)phenoxy]-N,N-diethylethanamine citrate |
| Dosage (medical) |
Typically, 50 mg daily for 5 days at the beginning of the menstrual cycle |
| Dosage (sports) |
Commonly 25-50 mg per day during or at the end of a steroid cycle |
| Effects |
Induces ovulation, increases gonadotropin levels, raises serum testosterone levels |
| Formula |
C26H28ClNOв€™C6H8O7 |
| Half-life |
5-7 days |
| Hepatotoxicity |
Low, rare hepatic metabolism related side effects |
| Lab Test |
Can be detected in blood tests |
| Main action |
Induces ovulation by inhibiting negative feedback on the hypothalamus, increasing release of pituitary gonadotropins |
| Side effects |
Hot flashes, abdominal discomfort, visual disturbances, nausea, and headaches |
| Storage conditions |
Store at room temperature away from moisture and heat |
| Substance class |
Selective Estrogen Receptor Modulator (SERM) |
| Trade name |
Clomid, Serophene |
| Use in sports |
Used to restore the natural production of testosterone and minimize the effects of estrogen in the body after the use of anabolic steroids |
| Water Retention |
No significant water retention |
| Active ingredient, mg |
50 |
| Release form |
Pills |
| 1 Pill, mg |
50 |
| Manufacturer |
Anpharm Hellas |
| Packing |
Blister (12 Pills), Packing (2 blisters) |
